Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma

被引：0
作者：
Amanda Lassen
Mohammad Atefi
Lidia Robert
Deborah JL Wong
Michael Cerniglia
Begonya Comin-Anduix
Antoni Ribas
机构：
[1] University of California Los Angeles (UCLA),Department of Medicine, Division of Hematology
[2] University of California Los Angeles (UCLA),Oncology, David Geffen School of Medicine
[3] University of California Los Angeles (UCLA),Department of Surgery, Division of Surgical Oncology, David Geffen School of Medicine
[4] Jonsson Comprehensive Cancer Center (JCCC),Department of Molecular and Medical Pharmacology, David Geffen School of Medicine
[5] UCLA,Department of Medicine, Division of Hematology
[6] Jonsson Comprehensive Cancer Center at UCLA,Oncology, 11
来源：
Molecular Cancer | / 13卷
关键词：
Melanoma; AKT inhibitor; Dabrafenib; Combination therapy; Drug resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 581 条
  • [1] Sondergaard JN(2010)Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032 J Transl Med 8 39-599
  • [2] Nazarian R(2010)Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma Nature 467 596-365
  • [3] Wang Q(2012)Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial Lancet 380 358-714
  • [4] Guo D(2012)Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib N Engl J Med 366 707-209
  • [5] Hsueh T(2011)Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma Biochem Pharmacol 82 201-977
  • [6] Mok S(2010)Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation Nature 468 973-390
  • [7] Sazegar H(2012)Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance Nat Commun 3 724-972
  • [8] MacConaill LE(2011)RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Nature 480 387-3096
  • [9] Barretina JG(2010)COT drives resistance to RAF inhibition through MAP kinase pathway reactivation Nature 468 968-20416
  • [10] Kehoe SM(2011)Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling J Clin Oncol 29 3085-1703
12345678910